1Laboratory of Rare Human Circulating Cells (LCCRH) and Liquid Biopsy, University Medical Centre of Montpellier, Montpellier, France. 2CREEC (CREES), Unité Mixte de Recherches, IRD 224–CNRS ...

Abstract. Diffuse gastric cancer (DGC) is a highly lethal malignancy with only minimally effective systemic therapies. Our previous studies identified the Focal Adhesion Kinase (FAK) as a novel and ...

Morehouse School of Medicine, Atlanta, GA.

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...

1Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

At today’s Senate Health, Education, Labor, and Pensions Committee hearing, nominee for Secretary of the Department of Health and Human Services Robert F. Kennedy (RFK) Jr. refused to renounce his ...

1Medical Department of Hematology, Oncology and Tumor Immunology, Molekulares Krebsforschungszentrum – MKFZ, Campus Virchow Klinikum, Charité - Universitätsmedizin, Berlin, Germany.

Major Finding: Incorporating a modified CD3ε intracellular domain into a chimeric antigen receptor (E-CAR) improves signaling. Concept: E-CARs phase separate and form mature synapses that support ...

1Colorado School of Public Health, University of Colorado Comprehensive Cancer Center, Aurora, Colorado. *Corresponding Author: Cathy J. Bradley, Department of Health Systems, Management, and Policy, ...

Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.

1Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain. 2Navarra Institute for Health Research (IDISNA), Pamplona, Spain. 3Centro de Investigación Biomédica en Red de ...

1Basser Center for BRCA1/2, University of Pennsylvania, Philadelphia, Pen­nsylvania. 2Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.